Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin on Atherosclerosis, ß-Cell Function, and Glycemic Control in Japanese Patients with Type 2 Diabetes Mellitus Who are Treatment Naïve or Poorly Responsive to Antidiabetes Agents: A Multicenter, Prospective Observational, Uncontrolled Study.

Tsurutani, Yuya; Omura, Masao; Matsuzawa, Yoko; Saito, Jun; Higa, Mariko; Taniyama, Matsuo; Nishikawa, Tetsuo

Tsurutani, Yuya; Omura, Masao; Matsuzawa, Yoko; Saito, Jun; Higa, Mariko; Taniyama, Matsuo; Nishikawa, Tetsuo.

Afiliación

Tsurutani Y; Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Yokohama, Japan.
Omura M; Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Yokohama, Japan.
Matsuzawa Y; Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Yokohama, Japan.
Saito J; Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Yokohama, Japan.
Higa M; Division of Diabetology and Endocrinology, Department of Internal Medicine, Saiseikai Yokohama-shi Tobu Hospital, Yokohama, Japan.
Taniyama M; Endocrinology and Metabolism, Showa University Fujigaoka Hospital, Yokohama, Japan.
Nishikawa T; Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Yokohama, Japan.

Curr Ther Res Clin Exp ; 84: 26-31, 2017.

Article en En | MEDLINE | ID: mdl-28761576

Palabras clave

dipeptidyl peptidase-4 inhibitor; pentraxin-3; proinsulin/insulin ratio; sitagliptin

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Idioma: En Revista: Curr Ther Res Clin Exp Año: 2017 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google